Search
Displaying 1 result
Ruxolitinib Mechanism of Action Action Pathway
smpdb.ca/view/SMP0126971Drug actionRuxolitinib is a selective and potent inhibitor of JAK2 and JAK1, with some affinity against JAK3 and TYK2. … Anticancer effects of ruxolitinib are attributed to its inhibition of JAKs and JAK-mediated phosphorylation of STAT3.
Drugs: Ruxolitinib